Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer (SORAMIC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by University of Magdeburg
Sponsor:
Collaborators:
Bayer
Sirtex Medical
Information provided by (Responsible Party):
Jens Ricke, University of Magdeburg
ClinicalTrials.gov Identifier:
NCT01126645
First received: May 17, 2010
Last updated: December 2, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)